Creative Medical Technology Holdings Inc —— 财务报表 (NASDAQ:CELZ) | MetaTrader

展开完整图表

新闻

Creative Medical receives WHO designation for second cell therapy

创意医疗公司报告背痛疗法中期数据积极

Creative Medical reports positive interim data for back pain therapy

Creative Medical’s BioDefense initiative receives regulatory approval

创意医疗科技股东批准权证行权提案

Creative Medical Technology stockholders approve warrant exercise proposal

创意医疗完成慢性背痛临床试验患者招募

Creative Medical completes enrollment in chronic back pain trial

WHO approves olastrocel as international name for CELZ-201 therapy

创意医疗科技控股公司批准CEO和CFO奖金

Creative Medical Technology Holdings approves bonuses for CEO and CFO

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now